MELA Sciences (NASDAQ:MELA)

CAPS Rating: 2 out of 5

A medical device company which focuses on designing and development of a non-invasive, point-of-care instrument to assist in the early diagnosis of melanoma.

Recs

0
Player Avatar Maribaza (26.67) Submitted: 11/19/2010 10:59:16 AM : Underperform Start Price: $5.05 MELA Score: +57.01

37,11,163,7,6

Featured Broker Partners


Advertisement